The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-{(E)-2-[2-Benzylphenyl]vinyloxy}ethyl)nipecotic acid ID: ALA2387666
PubChem CID: 71660388
Max Phase: Preclinical
Molecular Formula: C23H27NO3
Molecular Weight: 365.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)C1CCCN(CCO/C=C/c2ccccc2Cc2ccccc2)C1
Standard InChI: InChI=1S/C23H27NO3/c25-23(26)22-11-6-13-24(18-22)14-16-27-15-12-20-9-4-5-10-21(20)17-19-7-2-1-3-8-19/h1-5,7-10,12,15,22H,6,11,13-14,16-18H2,(H,25,26)/b15-12+
Standard InChI Key: ZYHNOHYSMANAKL-NTCAYCPXSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
3.0837 -9.0544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4962 -8.3399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0837 -7.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4962 -6.9110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3212 -6.9110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7337 -7.6254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3212 -8.3399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4962 -9.7688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2587 -9.0544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5587 -7.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9712 -8.3399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7962 -8.3399 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2087 -9.0544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0337 -9.0544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4462 -9.7688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2712 -9.7688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6837 -10.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2712 -11.1978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4462 -11.1978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0337 -10.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6837 -9.0544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5087 -9.0544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9212 -8.3399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7462 -8.3399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1587 -9.0544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7462 -9.7688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9212 -9.7688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
2 7 1 0
1 8 2 0
1 9 1 0
10 11 1 0
13 14 2 0
12 13 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
22 27 2 0
16 21 1 0
14 15 1 0
11 12 1 0
6 10 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 365.47Molecular Weight (Monoisotopic): 365.1991AlogP: 4.06#Rotatable Bonds: 8Polar Surface Area: 49.77Molecular Species: ZWITTERIONHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.57CX Basic pKa: 9.34CX LogP: 1.84CX LogD: 1.84Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.57Np Likeness Score: -0.20
References 1. Quandt G, Höfner G, Wanner KT.. (2013) Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors., 21 (11): [PMID:23598250 ] [10.1016/j.bmc.2013.02.056 ]